169 related articles for article (PubMed ID: 36287174)
1. Computational study on new natural compound inhibitors of Traf2 and Nck-interacting kinase (TNIK).
Ma L; Li R; Yao Z; Wang B; Liu Y; Liu C; Wang H; Chen S; Sun D
Aging (Albany NY); 2022 Oct; 14(20):8394-8410. PubMed ID: 36287174
[TBL] [Abstract][Full Text] [Related]
2. Jatrorrhizine inhibits mammary carcinoma cells by targeting TNIK mediated Wnt/β-catenin signalling and epithelial-mesenchymal transition (EMT).
Sun Y; Gao X; Wu P; Wink M; Li J; Dian L; Liang Z
Phytomedicine; 2019 Oct; 63():153015. PubMed ID: 31302315
[TBL] [Abstract][Full Text] [Related]
3. Structural Insight into TNIK Inhibition.
Kukimoto-Niino M; Shirouzu M; Yamada T
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361804
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic targets in the Wnt signaling pathway: Feasibility of targeting TNIK in colorectal cancer.
Masuda M; Sawa M; Yamada T
Pharmacol Ther; 2015 Dec; 156():1-9. PubMed ID: 26542362
[TBL] [Abstract][Full Text] [Related]
5. Fragment growth-based discovery of novel TNIK inhibitors for the treatment of colorectal cancer.
Teng Y; Wu R; Bo W; Tang M; Wang T; Cui X; Li Y; Zhang C; Ma Z; Fu Z; Xu Q; Liu J; Chen L
Eur J Med Chem; 2024 Mar; 268():116240. PubMed ID: 38422698
[TBL] [Abstract][Full Text] [Related]
6. A novel aminothiazole KY-05009 with potential to inhibit Traf2- and Nck-interacting kinase (TNIK) attenuates TGF-β1-mediated epithelial-to-mesenchymal transition in human lung adenocarcinoma A549 cells.
Kim J; Moon SH; Kim BT; Chae CH; Lee JY; Kim SH
PLoS One; 2014; 9(10):e110180. PubMed ID: 25337707
[TBL] [Abstract][Full Text] [Related]
7. Emergence of TNIK inhibitors in cancer therapeutics.
Yamada T; Masuda M
Cancer Sci; 2017 May; 108(5):818-823. PubMed ID: 28208209
[TBL] [Abstract][Full Text] [Related]
8. TNIK inhibition abrogates colorectal cancer stemness.
Masuda M; Uno Y; Ohbayashi N; Ohata H; Mimata A; Kukimoto-Niino M; Moriyama H; Kashimoto S; Inoue T; Goto N; Okamoto K; Shirouzu M; Sawa M; Yamada T
Nat Commun; 2016 Aug; 7():12586. PubMed ID: 27562646
[TBL] [Abstract][Full Text] [Related]
9. Traf2- and Nck-interacting kinase (TNIK) is involved in the anti-cancer mechanism of dovitinib in human multiple myeloma IM-9 cells.
Chon HJ; Lee Y; Bae KJ; Byun BJ; Kim SA; Kim J
Amino Acids; 2016 Jul; 48(7):1591-9. PubMed ID: 26995282
[TBL] [Abstract][Full Text] [Related]
10. Synergistic inhibition effect of TNIK inhibitor KY-05009 and receptor tyrosine kinase inhibitor dovitinib on IL-6-induced proliferation and Wnt signaling pathway in human multiple myeloma cells.
Lee Y; Jung JI; Park KY; Kim SA; Kim J
Oncotarget; 2017 Jun; 8(25):41091-41101. PubMed ID: 28467797
[TBL] [Abstract][Full Text] [Related]
11. Traf2- and Nck-interacting kinase is essential for Wnt signaling and colorectal cancer growth.
Shitashige M; Satow R; Jigami T; Aoki K; Honda K; Shibata T; Ono M; Hirohashi S; Yamada T
Cancer Res; 2010 Jun; 70(12):5024-33. PubMed ID: 20530691
[TBL] [Abstract][Full Text] [Related]
12. TNIK influence the effects of antipsychotics on Wnt/β-catenin signaling pathway.
Yuan R; Li Y; Fu Y; Ning A; Wang D; Zhang R; Yu S; Xu Q
Psychopharmacology (Berl); 2021 Nov; 238(11):3283-3292. PubMed ID: 34350475
[TBL] [Abstract][Full Text] [Related]
13. Discovery of 3,4-Dihydrobenzo[
Li Y; Zhang L; Yang R; Qiao Z; Wu M; Huang C; Tian C; Luo X; Yang W; Zhang Y; Li L; Yang S
J Med Chem; 2022 Feb; 65(3):1786-1807. PubMed ID: 34985886
[TBL] [Abstract][Full Text] [Related]
14. Nuclear expression of phosphorylated TRAF2- and NCK-interacting kinase in hepatocellular carcinoma is associated with poor prognosis.
Jin J; Jung HY; Wang Y; Xie J; Yeom YI; Jang JJ; Lee KB
Pathol Res Pract; 2014 Oct; 210(10):621-7. PubMed ID: 25160513
[TBL] [Abstract][Full Text] [Related]
15. Role of the Rap2/TNIK kinase pathway in regulation of LRP6 stability for Wnt signaling.
Park DS; Seo JH; Hong M; Choi SC
Biochem Biophys Res Commun; 2013 Jun; 436(2):338-43. PubMed ID: 23743195
[TBL] [Abstract][Full Text] [Related]
16. Discovery of 4-phenyl-2-phenylaminopyridine based TNIK inhibitors.
Ho KK; Parnell KM; Yuan Y; Xu Y; Kultgen SG; Hamblin S; Hendrickson TF; Luo B; Foulks JM; McCullar MV; Kanner SB
Bioorg Med Chem Lett; 2013 Jan; 23(2):569-73. PubMed ID: 23232060
[TBL] [Abstract][Full Text] [Related]
17. Discovery of benzo[d]oxazol-2(3H)-one derivatives as a new class of TNIK inhibitors for the treatment of colorectal cancer.
Luo X; Yang R; Li Y; Zhang L; Yang S; Li L
Bioorg Med Chem Lett; 2022 Jul; 67():128745. PubMed ID: 35447345
[TBL] [Abstract][Full Text] [Related]
18. Targeting the Wnt signaling pathway in colorectal cancer.
Sawa M; Masuda M; Yamada T
Expert Opin Ther Targets; 2016; 20(4):419-29. PubMed ID: 26439805
[TBL] [Abstract][Full Text] [Related]
19. The kinase TNIK is an essential activator of Wnt target genes.
Mahmoudi T; Li VS; Ng SS; Taouatas N; Vries RG; Mohammed S; Heck AJ; Clevers H
EMBO J; 2009 Nov; 28(21):3329-40. PubMed ID: 19816403
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Wnt Signaling in Colon Cancer Cells via an Oral Drug that Facilitates TNIK Degradation.
Zhou K; Cheong JE; Krishnaji ST; Ghalali A; Fu H; Sui L; Alix-Panabières C; Cayrefourcq L; Bielenberg D; Sun L; Zetter B
Mol Cancer Ther; 2023 Jan; 22(1):25-36. PubMed ID: 36302395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
